• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在结肠癌细胞系中,γ干扰素可改变肿瘤坏死因子α诱导凋亡时的Bcl-xL/Bax比率,但对肿瘤坏死因子相关凋亡诱导配体诱导凋亡时的该比率无影响。

Bcl-xL/Bax ratio is altered by IFNgamma in TNFalpha- but not in TRAIL-induced apoptosis in colon cancer cell line.

作者信息

Baillat Gilbert, Garrouste Francoise, Remacle-Bonnet Maryse, Marvaldi Jacques, Pommier Gilbert

机构信息

ISPDCT (IPHM), FRE CNRS 2737, Université de la Méditerranée, Faculté de Pharmacie, 27 Bd. Jean Moulin, 13385 Marseille Cedex 5, France.

出版信息

Biochim Biophys Acta. 2005 Aug 15;1745(1):101-10. doi: 10.1016/j.bbamcr.2004.12.005. Epub 2005 Jan 11.

DOI:10.1016/j.bbamcr.2004.12.005
PMID:16085058
Abstract

Apoptosis is a crucial mechanism to eliminate harmful cells in which growth factors and cytokines are key regulators. In HT29-D4 cells, a model of human colon carcinoma, IFNgamma presensitization is essential to induce an apoptotic response to TNFalpha whereas it only slightly enhances TRAIL-induced apoptosis. To compare the transcriptional profiles induced by TNFalpha and TRAIL and their regulation by IFNgamma, we optimized a cDNA array analysis on targeted signaling pathways and confirmed the gene expression modulations by comparative RT-PCR. Although the two TNFSF ligands induced a same strong up-expression of pro-apoptotic Bax gene, the expression of anti-apoptotic Bcl-xL gene was more strongly up-regulated in TNFalpha- than in TRAIL-stimulated cells. Thus, TRAIL but not TNFalpha induced apoptotic mitochondrial cascade as highlighted by cytochrome c release into cytosol. IFNgamma presensitization of TRAIL-stimulated cells did not induce any change in cytochrome c release, suggesting that the increase of IFNgamma/TRAIL-induced apoptosis is independent of this pathway. In contrast, IFNgamma pretreatment prevented Bcl-xL gene up-expression in TNFalpha-stimulated cells and allowed cytochrome c release. Thus, we hypothesize that the Bcl-xL/Bax ratio can block the apoptotic response in TNFalpha-stimulated cells but allows cell death initiation when it is altered by a crosstalk between IFNgamma presensitization and TNFalpha induced signalings.

摘要

细胞凋亡是消除有害细胞的关键机制,其中生长因子和细胞因子是关键调节因子。在人结肠癌模型HT29-D4细胞中,γ干扰素预致敏对于诱导对肿瘤坏死因子α的凋亡反应至关重要,而它仅略微增强肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡。为了比较肿瘤坏死因子α和TRAIL诱导的转录谱及其受γ干扰素的调节,我们优化了针对靶向信号通路的cDNA阵列分析,并通过比较逆转录聚合酶链反应(RT-PCR)证实了基因表达的调节。尽管这两种肿瘤坏死因子超家族(TNFSF)配体均诱导促凋亡的Bax基因强烈上调表达,但在肿瘤坏死因子α刺激的细胞中,抗凋亡的Bcl-xL基因的表达上调比TRAIL刺激的细胞中更强。因此,如细胞色素c释放到细胞质中所突出显示的,TRAIL而非肿瘤坏死因子α诱导凋亡线粒体级联反应。TRAIL刺激细胞的γ干扰素预致敏并未诱导细胞色素c释放的任何变化,这表明γ干扰素/TRAIL诱导的凋亡增加与该途径无关。相反,γ干扰素预处理可防止肿瘤坏死因子α刺激的细胞中Bcl-xL基因上调表达,并允许细胞色素c释放。因此,我们推测Bcl-xL/Bax比率可阻断肿瘤坏死因子α刺激的细胞中的凋亡反应,但当它因γ干扰素预致敏和肿瘤坏死因子α诱导的信号之间的串扰而改变时,则允许细胞死亡启动。

相似文献

1
Bcl-xL/Bax ratio is altered by IFNgamma in TNFalpha- but not in TRAIL-induced apoptosis in colon cancer cell line.在结肠癌细胞系中,γ干扰素可改变肿瘤坏死因子α诱导凋亡时的Bcl-xL/Bax比率,但对肿瘤坏死因子相关凋亡诱导配体诱导凋亡时的该比率无影响。
Biochim Biophys Acta. 2005 Aug 15;1745(1):101-10. doi: 10.1016/j.bbamcr.2004.12.005. Epub 2005 Jan 11.
2
Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.促凋亡分子Bax和Bak参与肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的线粒体破坏和凋亡:细胞色素c和Smac/DIABLO释放的差异调节
Cancer Res. 2003 Apr 1;63(7):1712-21.
3
Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.活性氧调节肿瘤坏死因子相关凋亡诱导配体耐药的人结肠癌细胞系中的半胱天冬酶激活。
Cancer Res. 2005 Aug 15;65(16):7436-45. doi: 10.1158/0008-5472.CAN-04-2628.
4
Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.Bcl-2抑制剂通过解偶联人白血病CEM细胞中的线粒体呼吸作用,使肿瘤坏死因子相关凋亡诱导配体诱导的凋亡变得敏感。
Cancer Res. 2004 May 15;64(10):3607-16. doi: 10.1158/0008-5472.CAN-03-3648.
5
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.通过抑制酪蛋白激酶II使肿瘤细胞对Apo2配体/TRAIL诱导的凋亡致敏。
Cancer Res. 2002 Aug 1;62(15):4180-5.
6
Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.黄酮哌啶醇与TRAIL/Apo2L之间强大的抗白血病相互作用涉及黄酮哌啶醇介导的XIAP下调。
Leukemia. 2004 Nov;18(11):1780-8. doi: 10.1038/sj.leu.2403491.
7
Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax.在I型白血病细胞中,由试验诱导的细胞凋亡不会因bax的过表达而增强。
Biochem Biophys Res Commun. 2001 May 25;283(5):1037-45. doi: 10.1006/bbrc.2001.4895.
8
Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation.缺氧通过阻断Bax易位来抑制肿瘤坏死因子相关凋亡诱导配体诱导的细胞凋亡。
Cancer Res. 2004 Jun 15;64(12):4078-81. doi: 10.1158/0008-5472.CAN-04-0284.
9
Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.PC-3前列腺癌细胞对肿瘤坏死因子相关凋亡诱导配体的凋亡反应性:Bcl-xL和Bcl-2下调的不同作用证据
Int J Oncol. 2004 Oct;25(4):1171-81.
10
Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.Apo2L/TRAIL对Bax基因缺陷型细胞中舒林酸和COX-2选择性非甾体抗炎药的凋亡效应具有不同的调节作用。
Oncogene. 2002 Sep 5;21(39):6032-40. doi: 10.1038/sj.onc.1205897.

引用本文的文献

1
NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.NORE1A 通过 ITCH 介导的 TNFRI 和 BAX 降解的相互调节来指导 TNF 信号的凋亡开关。
Oncogene. 2020 Aug;39(34):5675-5689. doi: 10.1038/s41388-020-01392-y. Epub 2020 Jul 20.
2
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.两条黑色素瘤细胞系中IFN-γ介导的HLA I类诱导性丧失的不同机制。
BMC Cancer. 2007 Feb 23;7:34. doi: 10.1186/1471-2407-7-34.